
1. Sci Immunol. 2020 Jan 10;5(43). pii: eaba7107. doi: 10.1126/sciimmunol.aba7107.

Cis-interactions Make Immune Checkpoint Blockade More Trans-parent.

Khatwani N(1)(2), Pillai AB(1)(2).

Author information: 
(1)Departments of Pediatrics and Microbiology and Immunology, University of Miami
Miller School of Medicine.
(2)Sylvester Comprehensive Cancer Center, University of Miami.

PD-L1:CD80 cis-heterodimer formation preferentially blocks CTLA-4 trans-signaling
while allowing CD28-mediated effector T cell activation.

DOI: 10.1126/sciimmunol.aba7107 
PMCID: PMC7861137
PMID: 33553964 

